Literature DB >> 8052997

A comparison of ovine and equine antivenoms.

L Sjostrom1, I H al-Abdulla, S Rawat, D C Smith, J Landon.   

Abstract

Commercial antivenoms produced in horses were compared with monospecific antivenoms raised in sheep against Crotalus durissus terrificus, Crotalus atrox, Crotalus adamanteus, Micrurus fulvius fulvius, Naja naja, Naja kaouthia, Echis ocellatus, Vipera lebetina deserti, Vipera berus berus and Vipera ammodytes ammodytes venom. Antibodies raised by immunizing sheep with C. d. terrificus venom were more effective than their equine counterparts in preventing lethal toxicity in mice (ED50), in inhibiting the venom's pharmacological effects (haemolysis, platelet aggregation and coagulation), and in neutralizing phospholipase A2 activity. Comparison of one ovine and three equine F(ab)2 products raised against V. a. ammodytes venom showed that all were at least 95% pure; that all protected mice; and that all contained antibody populations directed against most components of V. a. ammodytes and V. b. berus venoms. The ovine antivenoms generally contained a higher concentration of specific antibodies than the equine products. Finally, the ovine antivenoms raised against E. ocellatus, V. lebetina deserti, V. b. berus, M. f. fulvius and N. naja venoms provided better in vivo protection to mice than the equine antivenoms, but the equine antivenoms to N. kaouthia and C. atrox were more protective than the ovine product.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8052997     DOI: 10.1016/0041-0101(94)90294-1

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  7 in total

Review 1.  Antivenom therapy in the Americas.

Authors:  K Heard; G F O'Malley; R C Dart
Journal:  Drugs       Date:  1999-07       Impact factor: 9.546

2.  A Simple and Novel Strategy for the Production of a Pan-specific Antiserum against Elapid Snakes of Asia.

Authors:  Kavi Ratanabanangkoon; Kae Yi Tan; Sukanya Eursakun; Choo Hock Tan; Pavinee Simsiriwong; Teeraporn Pamornsakda; Witthawat Wiriyarat; Chaiya Klinpayom; Nget Hong Tan
Journal:  PLoS Negl Trop Dis       Date:  2016-04-08

3.  Preserved antiviral adaptive immunity following polyclonal antibody immunotherapy for severe murine influenza infection.

Authors:  Natalie E Stevens; Antoinette Hatjopolous; Cara K Fraser; Mohammed Alsharifi; Kerrilyn R Diener; John D Hayball
Journal:  Sci Rep       Date:  2016-07-06       Impact factor: 4.379

Review 4.  Egg yolk antibodies (IgY) and their applications in human and veterinary health: A review.

Authors:  E P V Pereira; M F van Tilburg; E O P T Florean; M I F Guedes
Journal:  Int Immunopharmacol       Date:  2019-05-22       Impact factor: 4.932

5.  An empirical approach towards the efficient and optimal production of influenza-neutralizing ovine polyclonal antibodies demonstrates that the novel adjuvant CoVaccine HT™ is functionally superior to Freund's adjuvant.

Authors:  Natalie E Stevens; Cara K Fraser; Mohammed Alsharifi; Michael P Brown; Kerrilyn R Diener; John D Hayball
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

6.  Toxicity of crude and detoxified Tityus serrulatus venom in anti-venom-producing sheep.

Authors:  Marina G Ferreira; Clara G Duarte; Maira S Oliveira; Karen L P Castro; Maílson S Teixeira; Lílian P G Reis; José A Zambrano; Evanguedes Kalapothakis; Ana Flávia R M Michel; Benito Soto-Blanco; Carlos Chávez-Olórtegui; Marília M Melo
Journal:  J Vet Sci       Date:  2016-12-30       Impact factor: 1.672

Review 7.  Benefits of using heterologous polyclonal antibodies and potential applications to new and undertreated infectious pathogens.

Authors:  Rashmi Dixit; Jenny Herz; Richard Dalton; Robert Booy
Journal:  Vaccine       Date:  2016-01-20       Impact factor: 3.641

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.